Why Melanoma Survivors Are Advised to Reduce Sun Exposure
After melanoma, protecting your skin from ultraviolet (UV) radiation becomes a key part of ongoing care. UV rays from the sun cause most melanomas. People who have had melanoma have a higher risk of getting a second skin cancer. The American Cancer Society advises melanoma survivors to limit sun exposure during peak hours, wear protective clothing, and use a broad-spectrum sunscreen with an SPF of at least 30. Follow-up care typically includes skin checks every 3 to 6 months for the first 3 to 5 years after treatment.
This caution makes sense. The challenge is that limiting UV exposure also limits vitamin D production in your skin – a nutrient that plays important roles in bone health and immune function. For melanoma survivors, this gap needs careful attention and a clear plan to manage it.
| Factor | Sun Exposure | Dietary Sources | Oral Supplementation (D3) |
|---|---|---|---|
| Suitability for melanoma survivors | Restricted – UV exposure raises risk of second primary melanoma | Suitable; no UV risk | Suitable; no UV risk |
| Typical contribution to serum 25(OH)D levels | Can be the main driver of vitamin D status in the general population, but not recommended for survivors | Low; dietary sources alone rarely maintain adequate serum levels without eating large amounts of fatty fish | Can reliably raise and maintain serum levels; trials in melanoma patients tested 100,000 IU per month under clinical supervision |
| Key practical concern | UV-related skin cancer risk | Low vitamin D content in most everyday foods | Doses above 4,000 IU per day long-term require medical supervision due to risk of elevated blood calcium |
| Evidence in melanoma survivorship | Not recommended as a vitamin D strategy for survivors | Limited trial data specific to melanoma | Studied in randomised controlled trials including the ViDMe trial and a stage II melanoma randomised placebo-controlled trial |
Sources: American Cancer Society melanoma follow-up care; ViDMe trial (PMC5569491); NCI Vitamin D Fact Sheet.
The Vitamin D Gap in Melanoma Survivorship
Your skin makes vitamin D when UVB radiation triggers a chemical reaction that converts a cholesterol-based compound into an early form of the vitamin. Your liver and kidneys then process this early form into its active form. For melanoma survivors who are limiting sun exposure, this production pathway is significantly reduced or stops.
People with a history of melanoma tend to have lower vitamin D levels compared to those without melanoma. A study of patients with metastatic melanoma found that vitamin D deficiency was linked to worse outcomes. Lower serum vitamin D at the time of diagnosis has also been linked to thicker tumors at presentation. These are associations, not proof of cause and effect. They do provide a reason for ensuring survivors maintain adequate levels through methods that do not involve UV exposure.
Cancer itself, or the stress of treatment, can also contribute to lower vitamin D levels independent of sun avoidance. Monitoring throughout the survivorship period is therefore important, not just at the time of diagnosis.
What Vitamin D Does for Bone Health
Vitamin D’s best-established role is in bone metabolism. It enables your intestines to absorb calcium from food. Without adequate vitamin D, calcium absorption drops. When blood calcium falls, your body pulls calcium out of bone tissue. Over time, this weakens bone density and raises the risk of osteoporosis and fractures.
According to the National Cancer Institute, a serum 25-hydroxyvitamin D level of 50 nmol/L (20 ng/mL) or higher is considered adequate for bone health and overall wellbeing in most adults. Levels below this are inadequate, and levels below 30 nmol/L (12 ng/mL) are classified as deficient.
For melanoma survivors who limit UV exposure significantly, reaching and maintaining that target through diet alone is difficult. Fatty fish, fortified dairy products, and eggs contain vitamin D, but dietary intake alone often falls short. Supplementation, guided by regular blood testing, is the most reliable approach.
Bone health is a concern across many cancer survivorship situations. The principles of management – testing to establish a baseline, supplementing to reach your target, and adding weight-bearing or resistance exercise – translate across cancer types. If bone density loss is also a concern for you, the article on vitamin D dosing and bone health in the context of prostate cancer and androgen deprivation therapy covers those principles in detail and shares several relevant overlaps with survivorship care more broadly.
Vitamin D and Immune Function: What the Evidence Shows in Melanoma
Vitamin D receptors sit on several types of immune cells, including T lymphocytes and natural killer (NK) cells. Lab work shows that vitamin D can influence the activity and behavior of these cells. Whether this matters for human health – and specifically for melanoma survivors – is an active area of clinical research.
Several randomised controlled trials have investigated vitamin D supplementation specifically in melanoma patients. This gives a more solid evidence base than is available for most complementary oncology topics.
The ViDMe trial, published in peer-reviewed literature, examined oral vitamin D supplementation in patients with cutaneous malignant melanoma. The trial found that 100,000 IU taken orally per month was safe and well tolerated over the study period. Researchers noted that reaching and maintaining adequate serum 25(OH)D was achievable through this approach without significant adverse effects.
A separate randomised placebo-controlled trial in patients with stage II melanoma examined vitamin D supplementation and disease-free survival. The results proved safe. As with the ViDMe trial, the researchers noted that larger studies are needed before firm conclusions about survival benefit can be drawn. The current evidence supports supplementation as a safe strategy for correcting vitamin D deficiency in melanoma survivors, while acknowledging that its direct effect on melanoma outcomes remains under investigation.
Supplementation: Dose, Form, and the Upper Limit
The most common supplemental form of vitamin D is vitamin D3, also called cholecalciferol. It is the same form your skin produces when exposed to UVB light. Evidence suggests that vitamin D3 is more effective than vitamin D2 (ergocalciferol) at raising and sustaining serum 25(OH)D levels when taken orally.
In clinical trials involving melanoma patients, researchers tested monthly oral doses of 100,000 IU and found them safe under clinical monitoring. In everyday clinical practice outside of trials, doctors usually recommend lower daily doses for long-term maintenance and adjust them based on baseline blood levels and individual response to supplementation.
The National Cancer Institute notes that the safe upper limit for vitamin D in adults is 4,000 IU per day from supplements used without specific medical direction. Sustained intake above this level without monitoring may raise blood calcium to unsafe levels. Symptoms can include nausea, weakness, and kidney complications. The high monthly doses used in clinical trials were conducted under regular monitoring of serum calcium and 25(OH)D – and this is why high-dose supplementation outside of a clinical setting requires clinician guidance before starting.
If you are researching formulations to discuss with your oncologist, you can see supplement options available as a starting point before that conversation.
Food Sources of Vitamin D Worth Including
Dietary vitamin D is a useful component of any vitamin D management strategy for melanoma survivors, even though food sources alone rarely maintain adequate serum levels in people avoiding regular sun exposure. The richest natural food sources include fatty fish such as salmon, mackerel, herring, and sardines. Egg yolks provide smaller amounts. Some mushrooms – particularly those exposed to UV light during production – can also contribute meaningful quantities.
Fortified foods, including certain cow’s milks, plant-based milks, and some orange juice products, also add to dietary vitamin D intake. The amount added varies by brand, so checking nutrition labels is a practical habit. Including a variety of these foods consistently creates a dietary base that complements supplementation. For most melanoma survivors limiting UV exposure, diet alone is unlikely to be sufficient to maintain serum 25(OH)D in the adequate range, but it remains a worthwhile contribution.
Testing Your Levels: The 25(OH)D Blood Test
The standard laboratory test for vitamin D status is the serum 25-hydroxyvitamin D test, written as 25(OH)D on most lab request forms. It measures the main form of vitamin D in your blood and gives the most reliable picture of your overall vitamin D status. This is a routine blood test that your doctor can order alongside the other tests included in standard melanoma follow-up care.
Asking for this test at each follow-up appointment allows your care team to track whether your current combination of diet and supplementation is keeping levels in the adequate range. If levels fall below 50 nmol/L (20 ng/mL), your oncologist or GP can recommend a supplementation dose to address the gap. If levels are already in range, the result confirms that your current approach is working.
Testing is the only reliable way to know whether your supplementation is effective or whether the dose needs to change. Without a baseline and follow-up results, you cannot know whether the approach is working. The 25(OH)D blood test is therefore a central part of vitamin D management in melanoma survivorship, not an optional step.
Bringing Vitamin D Into Your Survivorship Plan
Managing vitamin D levels is a practical and achievable part of melanoma survivorship. The core approach involves three steps: getting serum 25(OH)D tested at follow-up appointments, including vitamin D-rich foods in your regular diet, and discussing oral vitamin D3 supplementation with your oncologist if blood levels fall below the adequate threshold of 50 nmol/L (20 ng/mL).
The evidence reviewed here does not support vitamin D as a treatment for melanoma or as a substitute for any conventional therapy. What the evidence does support is that maintaining adequate levels matters for bone health, may help immune function, and is a goal your care team can help you achieve while you limit UV exposure. Cancer Research UK’s guidance on skin care after melanoma similarly emphasises sun protection alongside broader wellbeing – consistent with the need to actively manage the downstream effects of that protection, including vitamin D status.
If you are taking prescription medications, are pregnant, or are breastfeeding, speak to a clinician before adding any new supplement to your routine. This article is for general information and is not a substitute for medical advice. Always consult your oncologist or care team about your specific situation.
